US NIH Begins Human Trials of Universal Flu Vaccine

Published on September 15, 2023

The amazing folks over at the U.S. National Institutes of Health (NIH) have launched a super exciting study to test their new flu vaccine called FluMos-v2. This vaccine aims to protect against six different strains of the influenza virus, including four strains of influenza A. Think of it like having a superhero shield that defends you from multiple foes all at once! The NIH is taking charge in the never-ending battle against the flu, and this new vaccine could be a game-changer. If successful, it might mean no more guessing which strains will circulate each flu season, making flu shots even more effective and reducing the number of people falling victim to the winter illness. It’s early-stage research, but who knows? This could pave the way for a universal flu solution that could keep us all flu-free! Get ready to dive into the details of this groundbreaking study and learn more about the NIH’s innovative research.

The U.S. National Institutes of Health (NIH) said on Friday that it has begun an early-stage study on its experimental vaccine targeting six strains of influenza virus. The vaccine candidate, FluMos-v2, is designed to offer protection against four strains of the influenza A…

Read Full Article (External Site)

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes:

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>